Abstract: The present invention relates to a medicament for the treatment and/or prevention of cancer, the medicament being characterized by comprising an antibody having an immunological reactivity with CAPRIN-1 protein or a fragment of the antibody and a drug capable of inhibiting the N-glycoside-linked sugar chain synthesis of a glycoprotein which are combined with each other in a blended or separated form.
| # | Name | Date |
|---|---|---|
| 1 | 202417008198-STATEMENT OF UNDERTAKING (FORM 3) [07-02-2024(online)].pdf | 2024-02-07 |
| 3 | 202417008198-Sequence Listing in txt [07-02-2024(online)].txt | 2024-02-07 |
| 4 | 202417008198-Sequence Listing in PDF [07-02-2024(online)].pdf | 2024-02-07 |
| 5 | 202417008198-PROOF OF RIGHT [07-02-2024(online)].pdf | 2024-02-07 |
| 6 | 202417008198-POWER OF AUTHORITY [07-02-2024(online)].pdf | 2024-02-07 |
| 7 | 202417008198-FORM 1 [07-02-2024(online)].pdf | 2024-02-07 |
| 8 | 202417008198-FIGURE OF ABSTRACT [07-02-2024(online)].pdf | 2024-02-07 |
| 9 | 202417008198-DRAWINGS [07-02-2024(online)].pdf | 2024-02-07 |
| 10 | 202417008198-DECLARATION OF INVENTORSHIP (FORM 5) [07-02-2024(online)].pdf | 2024-02-07 |
| 11 | 202417008198-COMPLETE SPECIFICATION [07-02-2024(online)].pdf | 2024-02-07 |
| 12 | 202417008198-certified copy of translation [07-02-2024(online)].pdf | 2024-02-07 |
| 13 | 202417008198-Retyped Pages under Rule 14(1) [09-02-2024(online)].pdf | 2024-02-09 |
| 14 | 202417008198-2. Marked Copy under Rule 14(2) [09-02-2024(online)].pdf | 2024-02-09 |
| 15 | 202417008198-FORM 3 [02-08-2024(online)].pdf | 2024-08-02 |
| 16 | 202417008198-MARKED COPIES OF AMENDEMENTS [04-07-2025(online)].pdf | 2025-07-04 |
| 17 | 202417008198-FORM 18 [04-07-2025(online)].pdf | 2025-07-04 |
| 18 | 202417008198-FORM 13 [04-07-2025(online)].pdf | 2025-07-04 |
| 19 | 202417008198-AMMENDED DOCUMENTS [04-07-2025(online)].pdf | 2025-07-04 |